Laura Beil (Texas freelance author) "Frightening Introduction to the Stem Cell Clinics" - RegenMed SA
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Laura Beil (Texas freelance author)
“Frightening Introduction to the Stem Cell Clinics”
Laura Beil is an independent journalist specializing in medicine,
health policy and science. She was the recipient of the Victor
Cohn Prize for Medical Science Reporting in 2018, one of the top
awards in medical journalism. Her work has appeared in
numerous publications, including The New York Times,
Cosmopolitan, Reader's Digest, Texas Monthly, Men's
Health, and Science News. She began freelancing in 2007 after
working as medical writer for the Dallas Morning News from
1992 to 2006. In 2018, she reported and hosted the podcast Dr.
Death, which has been downloaded more than 50 million times. Her latest podcast, Bad
Batch, looks at the for-profit stem cell industry:
https://podcasts.apple.com/us/podcast/bad-batch/id1482851200
https://ipscell.com/2019/10/bad-batch-podcast-is-must-listen-for-stem-cell-community/
https://ipscell.com/2019/11/bad-batch-podcasts-dark-picture-of-perinatal-stem-cell-
industry/
Bruce Bunnell (Tulane University)
“What is a Stem Cell?”
Bruce Bunnell, PhD is the Director of the Tulane Center for
Stem Cell Research and Regenerative Medicine and Professor
in the Department of Pharmacology in the Tulane University
School of Medicine. In addition, he holds the Aron Family
Regents Distinguished Chair in Gene Therapy. Dr. Bunnell
obtained his PhD in Microbiology from the University of
Alabama at Birmingham School of Medicine. He then pursued
Postdoctoral Fellowship research at the Howard Hughes
Medical Institute in the School of Medicine at the University of
Michigan and the National Human Genome Research Institute at the National Institutes
of Health in Bethesda, MD. Dr. Bunnell was an Assistant Professor at the Nationwide
Children’s Hospital Research Institute, part of the Ohio State University School of
Medicine prior to joining the faculty at Tulane University in 2002. Dr. Bunnell's research
program is focused on both the basic science and translational applications of adult stem
cells isolated from the bone marrow and adipose tissue.
Jaime Garza (UT Health SA)
“How Do You Do a Clinical Trial the Right Way?”
Dr. Jaime Garza is currently Professor of Orthopedic Surgery,
Professor of Otolaryngology, Professor in the Center for Stem
Cell Research and Regenerative Medicine at Tulane University
School of Medicine; Professor of Surgery and Professor of
Otolaryngology at UT Health-SA. He was the Founder and
Chairman of their Division of Plastic and Reconstructive Surgery.
He served on the University’s Executive Committee as Associate
Vice President for South Texas Health Affairs. Dr. Garza is
President of the Texas Center for Cellular Therapy and Research
at the Texas Center for Athletes and is a past president of the Texas Society of Plastic
Surgeons. In 2011, then Texas Governor Rick Perry appointed Dr. Garza a Regent to the
Texas State University System, where he served as a two-term Chairman of the Board,
and is now serving his eighth year as chair of the Academic and Health Affairs
Committee and as a member of the Governmental Relations Committee. An accomplished
clinical researcher, he is one of the first clinician/scientists in the nation to receive an
Institutional Review Board approval for a research study involving the use of human
regenerative cells for the treatment of osteoarthritis of the human knee joint. His work
was published in The Journal of Regenerative Medicine. He is one of three principal
investigators in a national FDA approved Phase IIB stem cell trial for the treatment of
knee osteoarthritis that has been accepted for publication in The American Journal of
Sports Medicine.
Adrienne Mendoza (BioBridge Global)
“Manufacturing of Stem Cells – Quality and Regulatory Measures”
Adrienne Blevins Mendoza is BioBridge Global’s vice president of
Global Quality, reporting to Chief Compliance Officer (CCO)
Richey Wyatt. Adrienne serves on the company’s senior leadership
team and oversees all quality & regulatory compliance matters,
including strategies to delight the customer, improve execution of
all GxP relevant processes, control risks, and improve efficiencies
through Quality Systems Management. Adrienne joined BioBridge
Global in 2016 from a background in Pharmaceuticals and
Biologics, including Cell and Gene Therapies and Transfusion
Medicine spanning nearly 20 years. Prior to joining BioBridge
Global, she previously worked with Bachem, StemCyte, the American Red Cross Blood &
Tissue Services, and as a partner in Blevins CUBED Architects. Adrienne earned a bachelor’s
degree in Business Administration from California Coast University and participated in
Administrative and Executive Leadership programs at the Kellogg School of Management at
Northwestern, and the University of Oklahoma.
12:00 - Lunch (provided)
SESSION 4 [Session Chair – Jian Ling, SwRI]
1:00 - Bernard Arulanandam – UTSA
1:05 - Wensheng Zhang (USAF)
Exosome Analysis of Neural Regeneration
1:20 - Emily Boice (USA-ISR)
Isolation and Characterization of Extracellular Vesicles from Human Induced
Pluripotent Stem Cells for Neuroprotective Application Post Retinal Injury
1:40 - Steve Harris (UT Heath SA)
Interaction of the Estrogen Receptor, Wnt Signaling, and the Bmp Gene in
Periodontal Stem/Progenitor Cell Specification and Differentiation
2:05 - Guillermo Vela (NeuScience)
Using Computer Vision and Deep Learning to Assess Treatment Efficacy at the
Single Cell Level
2:30 - Conference adjourns
Poster Presentations
Notes
Notes
Notes
Notes
Notes
You can also read
